Delivery Order SPE2DB24D2100-SPE2DB25FBFJQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,488.40 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Briviact 100mg tablets (60 count) with a ceiling value of $2,786.04. This is a firm fixed-price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,799.70 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60 count) on May 6, 2025, with completion targeted for May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $2,804.93 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $11,044.73. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Briviact 100 mg tablets in a quantity of 60 units. This competitively awarded, non-set-aside contract carries a ceiling value of $3,043.64 under a firm fixed price arrangement, with an ultimate completion date of April 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against the...
- The Defense Logistics Agency awarded a $3,168.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of September 15, 2025. The award, issued on September 12, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Briviact 100 mg tablets (60-count units) with a contract value of $1,073.25. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFJQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,976.41 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to deliver a broad spectrum of pharmaceutical products across multiple therapeutic domains to support Department of Defense healthcare requirements globally. This delivery order for Briviact, a psychiatric medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the military medical supply chain through the established prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/22/25 |